Dry eye questionnaires capture only 22.4% of Demodex blepharitis symptoms, and a 22-study review links Demodex infestation to worse meibomian gland function.
|Videos|March 11, 2022
The ocular surface and makeup: What you need to know
Author(s)Pam Theriot, OD, FAAO, Brooke Henson, Editor
Pamela Theriot OD, FAAO, on highlights from her SECO 2022 presentation "Makeup and the ocular surface: what you need to know"
Advertisement
Pamela Theriot, OD, FAAP, founder and director of the Dry Eye Center at Lusk Eye Specialists in Shreveport, Louisianna, speaks with Optometry Times®' Brooke Henson on highlights from her presentation "Makeup and the ocular surface: what you need to know."
Advertisement
Related to this article
Real-world PFHO data show OSDI scores falling within 2 weeks, while a 12-month trial finds stable corneal endothelial cell density with cyclosporine 0.1%.
Presenters from AAOpt26's research symposium share their findings, applications for optometric practice, and goals for future study.
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what he hopes to see in 2027.
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026.
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
Jamie Kuzniar, OD, FAAO, FSLS, discusses a case-based AAOpt 2026 session on scleral lens complications, fitting around cross-linking, and advice for new graduates.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
2
FDA approves subcutaneous Enspryng for TED
3
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
4
FAQ: What clinicians should know as SYD-101 heads to FDA advisory committee
5